
Casey Shea Hagopian
Examiner (ID: 14598, Phone: (571)272-6097 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617, 1615 |
| Total Applications | 833 |
| Issued Applications | 324 |
| Pending Applications | 170 |
| Abandoned Applications | 363 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10540691
[patent_doc_number] => 09265794
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Insulin-mimetics as therapeutic adjuncts for bone regeneration'
[patent_app_type] => utility
[patent_app_number] => 14/469549
[patent_app_country] => US
[patent_app_date] => 2014-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 22951
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14469549
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/469549 | Insulin-mimetics as therapeutic adjuncts for bone regeneration | Aug 25, 2014 | Issued |
Array
(
[id] => 10960482
[patent_doc_number] => 20140363502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'Resveratrol-Containing Compositions and Methods of Use for Treatment of Macular Degeneration'
[patent_app_type] => utility
[patent_app_number] => 14/467704
[patent_app_country] => US
[patent_app_date] => 2014-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 64405
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14467704
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/467704 | Resveratrol-Containing Compositions and Methods of Use for Treatment of Macular Degeneration | Aug 24, 2014 | Abandoned |
Array
(
[id] => 9895144
[patent_doc_number] => 20150050344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR UPREGULATING HIPPOCAMPAL PLASTICITY AND HIPPOCAMPUS-DEPENDENT LEARNING AND MEMORY'
[patent_app_type] => utility
[patent_app_number] => 14/339387
[patent_app_country] => US
[patent_app_date] => 2014-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 33990
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14339387
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/339387 | COMPOSITIONS AND METHODS FOR UPREGULATING HIPPOCAMPAL PLASTICITY AND HIPPOCAMPUS-DEPENDENT LEARNING AND MEMORY | Jul 22, 2014 | Abandoned |
Array
(
[id] => 11633895
[patent_doc_number] => 09655851
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Granular material for dosage forms'
[patent_app_type] => utility
[patent_app_number] => 14/316879
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8674
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14316879
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/316879 | Granular material for dosage forms | Jun 26, 2014 | Issued |
Array
(
[id] => 9839645
[patent_doc_number] => 20150031728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures'
[patent_app_type] => utility
[patent_app_number] => 14/316008
[patent_app_country] => US
[patent_app_date] => 2014-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18676
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14316008
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/316008 | Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures | Jun 25, 2014 | Abandoned |
Array
(
[id] => 12246314
[patent_doc_number] => 09919077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Co-precipitation of a therapeutic agent into hydroxyapatite coatings'
[patent_app_type] => utility
[patent_app_number] => 14/897352
[patent_app_country] => US
[patent_app_date] => 2014-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 6111
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897352
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/897352 | Co-precipitation of a therapeutic agent into hydroxyapatite coatings | Jun 18, 2014 | Issued |
Array
(
[id] => 10256483
[patent_doc_number] => 20150141481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'Treatment of Chronic Obstructive Pulmonary Disease with Nebulized Beta 2-Agonist or Combined Nebulized Beta 2-Agonist and Anticholinergic Administration'
[patent_app_type] => utility
[patent_app_number] => 14/306525
[patent_app_country] => US
[patent_app_date] => 2014-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32804
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14306525
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/306525 | Treatment of Chronic Obstructive Pulmonary Disease with Nebulized Beta 2-Agonist or Combined Nebulized Beta 2-Agonist and Anticholinergic Administration | Jun 16, 2014 | Abandoned |
Array
(
[id] => 13125807
[patent_doc_number] => 10080818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Solid forms for tissue repair
[patent_app_type] => utility
[patent_app_number] => 14/302184
[patent_app_country] => US
[patent_app_date] => 2014-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 35
[patent_no_of_words] => 25695
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14302184
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/302184 | Solid forms for tissue repair | Jun 10, 2014 | Issued |
Array
(
[id] => 12210521
[patent_doc_number] => 09907311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Anti-odour and antibacterial fabric in textile goods'
[patent_app_type] => utility
[patent_app_number] => 14/298727
[patent_app_country] => US
[patent_app_date] => 2014-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1479
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14298727
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/298727 | Anti-odour and antibacterial fabric in textile goods | Jun 5, 2014 | Issued |
Array
(
[id] => 10559647
[patent_doc_number] => 09283299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-15
[patent_title] => 'Injectable hydrogels'
[patent_app_type] => utility
[patent_app_number] => 14/298170
[patent_app_country] => US
[patent_app_date] => 2014-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 69
[patent_no_of_words] => 15311
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14298170
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/298170 | Injectable hydrogels | Jun 5, 2014 | Issued |
Array
(
[id] => 13760909
[patent_doc_number] => 10172783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => High UV protection alcohol-free anhydrous clear system
[patent_app_type] => utility
[patent_app_number] => 14/295744
[patent_app_country] => US
[patent_app_date] => 2014-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2894
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14295744
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/295744 | High UV protection alcohol-free anhydrous clear system | Jun 3, 2014 | Issued |
Array
(
[id] => 9735808
[patent_doc_number] => 20140271520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'NON-WEIGHING HAIR PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/291329
[patent_app_country] => US
[patent_app_date] => 2014-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14848
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14291329
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/291329 | NON-WEIGHING HAIR PREPARATIONS | May 29, 2014 | Abandoned |
Array
(
[id] => 10774031
[patent_doc_number] => 20160120186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'ENHANCEMENT AND CONTROL OF SEED GERMINATION WITH COMPOSITIONS COMPRISING A TRANSITION METAL CATALYST AND AN OXIDANT'
[patent_app_type] => utility
[patent_app_number] => 14/894318
[patent_app_country] => US
[patent_app_date] => 2014-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20417
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894318
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/894318 | ENHANCEMENT AND CONTROL OF SEED GERMINATION WITH COMPOSITIONS COMPRISING A TRANSITION METAL CATALYST AND AN OXIDANT | May 28, 2014 | Pending |
Array
(
[id] => 12445659
[patent_doc_number] => 09981066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Anti-thrombogenic grafts
[patent_app_type] => utility
[patent_app_number] => 14/783897
[patent_app_country] => US
[patent_app_date] => 2014-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 17
[patent_no_of_words] => 16136
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783897
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/783897 | Anti-thrombogenic grafts | May 18, 2014 | Issued |
Array
(
[id] => 12165265
[patent_doc_number] => 09884024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition'
[patent_app_type] => utility
[patent_app_number] => 14/280677
[patent_app_country] => US
[patent_app_date] => 2014-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6790
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14280677
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/280677 | Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition | May 18, 2014 | Issued |
Array
(
[id] => 9838574
[patent_doc_number] => 20150030655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'PLGA SCAFFOLD'
[patent_app_type] => utility
[patent_app_number] => 14/273557
[patent_app_country] => US
[patent_app_date] => 2014-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6295
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14273557
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/273557 | PLGA scaffold | May 8, 2014 | Issued |
Array
(
[id] => 10579845
[patent_doc_number] => 09301957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Immediate release 4-methyl-3-4[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-YL)-3-(trifluoromethyl)phenyl] benzamide formulation'
[patent_app_type] => utility
[patent_app_number] => 14/273874
[patent_app_country] => US
[patent_app_date] => 2014-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6043
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14273874
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/273874 | Immediate release 4-methyl-3-4[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-YL)-3-(trifluoromethyl)phenyl] benzamide formulation | May 8, 2014 | Issued |
Array
(
[id] => 10727479
[patent_doc_number] => 20160073628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'High Osmolarity Antimicrobial Composition Containing One or More Organic Solvents'
[patent_app_type] => utility
[patent_app_number] => 14/888437
[patent_app_country] => US
[patent_app_date] => 2014-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14506
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888437
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/888437 | High osmolarity antimicrobial composition containing one or more organic solvents | May 1, 2014 | Issued |
Array
(
[id] => 10919123
[patent_doc_number] => 20140322142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'PARTICLE SIZE REDUCTION OF AN ANTIMUSCARINIC COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/258147
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7636
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258147
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/258147 | Particle size reduction of an antimuscarinic compound | Apr 21, 2014 | Issued |
Array
(
[id] => 9643099
[patent_doc_number] => 20140221212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'MICROCAPSULES ADAPTED TO RUPTURE IN A MAGNETIC FIELD'
[patent_app_type] => utility
[patent_app_number] => 14/244921
[patent_app_country] => US
[patent_app_date] => 2014-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10202
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14244921
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/244921 | Microcapsules adapted to rupture in a magnetic field | Apr 3, 2014 | Issued |